Sinopharm Group Co. Ltd. released an announcement outlining its Board composition as of 6 November 2025 in Shanghai, the PRC. The Board includes Non-Executive Directors chaired by Zhao Bingxiang, along with Chen Qiyu, Zu Jing, Xing Yonggang, Chen Yuqing, Wen Deyong, and Feng Rongli. The Executive Director is President Lian Wanyong. The Independent Non-Executive Directors are Li Peiyu, Wu Tak Lung, Yu Weifeng, Shi Shenghao, and Chen Weiru.

The announcement specifies the formation of five Board committees: Audit, Remuneration, Nomination, Strategy and Investment, and Legal and Compliance and Environmental, Social and Governance. Each Board member serves in their respective roles, with some acting as chairpersons and others as committee members, reflecting a structured governance framework. The updated arrangement aims to ensure strategic decision-making, compliance, and effective oversight within the organization.